Abstract
Bone marrow transplant (BMT) is done by the replacement of damaged bone marrow with healthy one. These healthy bone marrow cells (BMCs) are usually collected from the crest of the Ilium in humans hence these cells are used to replace damaged ones in the treatment of bone marrow related diseases such as leukemia, aplastic anemia, congenital immunodeficiency and autoimmune diseases. Even though there are different methods, perfusion method is one of the simple, safe and less contaminated methods used to harvest BMCs and it can reduce the risk in allogenic BMT. Intra bone marrow – bone marrow transfer (IBM-BMT) is one of the best procedures for allogenic BMT. Due to enlisting of hematopoietic stem cells and mesenchymal stem cells, which are derived from donor, this method has distinguishable advantages in allogenic BMT. In this paper the perfusion method (for harvesting BMCs) and IBM-BMT (for their transplantation) have been critically reviewed and showed that both methods are together will become an effective combination in allogeneic BMT.
Keywords: Allogeneic bone marrow transplantation, bone marrow cells, human stem cells, mesenchymal stem cells, intra-bone marrow bone marrow transplantation, perfusion method.
Current Stem Cell Research & Therapy
Title:A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation
Volume: 9 Issue: 6
Author(s): Narasimhulu Korrapati and Harikrishna Y. Nanganuru
Affiliation:
Keywords: Allogeneic bone marrow transplantation, bone marrow cells, human stem cells, mesenchymal stem cells, intra-bone marrow bone marrow transplantation, perfusion method.
Abstract: Bone marrow transplant (BMT) is done by the replacement of damaged bone marrow with healthy one. These healthy bone marrow cells (BMCs) are usually collected from the crest of the Ilium in humans hence these cells are used to replace damaged ones in the treatment of bone marrow related diseases such as leukemia, aplastic anemia, congenital immunodeficiency and autoimmune diseases. Even though there are different methods, perfusion method is one of the simple, safe and less contaminated methods used to harvest BMCs and it can reduce the risk in allogenic BMT. Intra bone marrow – bone marrow transfer (IBM-BMT) is one of the best procedures for allogenic BMT. Due to enlisting of hematopoietic stem cells and mesenchymal stem cells, which are derived from donor, this method has distinguishable advantages in allogenic BMT. In this paper the perfusion method (for harvesting BMCs) and IBM-BMT (for their transplantation) have been critically reviewed and showed that both methods are together will become an effective combination in allogeneic BMT.
Export Options
About this article
Cite this article as:
Korrapati Narasimhulu and Nanganuru Y. Harikrishna, A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation, Current Stem Cell Research & Therapy 2014; 9 (6) . https://dx.doi.org/10.2174/1574888X0906140930110950
DOI https://dx.doi.org/10.2174/1574888X0906140930110950 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Diterpenoids of the Genus Elaeoselinum (Apiaceae) and their Biological Properties
Current Organic Chemistry Adeno-Associated Virus-Mediated Gene Transfer in Hematopoietic Stem/Progenitor Cells as a Therapeutic Tool
Current Gene Therapy Sources of β-Cells for Cell Therapy in Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Advances in Stem Cell Therapy for Leukemia
Current Stem Cell Research & Therapy Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Current Pharmaceutical Design Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets Epigenetics in Brain Tumors: HDACs Take Center Stage
Current Neuropharmacology Metallothioneins and Cancer
Current Protein & Peptide Science Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement
Current Medicinal Chemistry Current and Emerging Therapeutic Approaches in HCV-Related Mixed Cryoglobulinemia
Current Medicinal Chemistry Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer
Current Medicinal Chemistry Gene Modified Cell Transplantation for Vascular Regeneration
Current Gene Therapy Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy
Current Drug Targets Preface [Hot Topic: Marine Natural Products (Guest Editor: Vassilios Roussis)]
Current Medicinal Chemistry Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery
Current Nanoscience Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Preclinical Studies of PROTACs in Hematological Malignancies
Cardiovascular & Hematological Disorders-Drug Targets Synthetic and Biological Aspects of Thiadiazoles and their Condensed Derivatives: An Overview
Current Topics in Medicinal Chemistry The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets Synthesis of Novel Coumarin Derivatives 7,8-Fused onto Thiazole
Letters in Organic Chemistry